The ARRY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARRY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARRY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARRY Detailed Price Forecast - CNN Money||View ARRY Detailed Summary - Google Finance|
|View ARRY Detailed Summary - Yahoo! Finance||View ARRY Stock Research & Analysis - Zacks.com|
|View ARRY Trends & Analysis - Trade-Ideas||View ARRY Major Holders - Barrons|
|View ARRY Call Transcripts - NASDAQ||View ARRY Breaking News & Analysis - Seeking Alpha|
|View ARRY Annual Report - CompanySpotlight.com||View ARRY OTC Short Report - OTCShortReport.com|
|View ARRY Fundamentals - TradeKing||View ARRY SEC Filings - Bar Chart|
|View Historical Prices for ARRY - The WSJ||View Performance/Total Return for ARRY - Morningstar|
|View the Analyst Estimates for ARRY - MarketWatch||View the Earnings History for ARRY - CNBC|
|View the ARRY Earnings - StockMarketWatch||View ARRY Buy or Sell Recommendations - MacroAxis|
|View the ARRY Bullish Patterns - American Bulls||View ARRY Short Pain Metrics - ShortPainBot.com|
|View ARRY Stock Mentions - StockTwits||View ARRY Stock Mentions - PennyStockTweets|
|View ARRY Stock Mentions - Twitter||View ARRY Investment Forum News - Investor Hub|
|View ARRY Stock Mentions - Yahoo! Message Board||View ARRY Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARRY - SECform4.com||View Insider Transactions for ARRY - Insider Cow|
|View ARRY Major Holdings Summary - CNBC||View Insider Disclosure for ARRY - OTC Markets|
|View Insider Transactions for ARRY - Yahoo! Finance||View Institutional Holdings for ARRY - NASDAQ|
|View ARRY Stock Insight & Charts - FinViz.com||View ARRY Investment Charts - StockCharts.com|
|View ARRY Stock Overview & Charts - BarChart||View ARRY User Generated Charts - Trading View|
European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
Posted on Thursday September 20, 2018
- European Commission approval applies to all 28 European Union member states, Liechtenstein, Iceland and Norway - - Approval is based on Phase 3 COLUMBUS trial which demonstrated nearly 15 months median ...
See what the IHS Markit Score report has to say about Array Biopharma Inc.
Posted on Thursday September 20, 2018
Over the last month, growth of ETFs holding ARRY is favorable, with net inflows of $4.78 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
Array BioPharma Announces Publication of BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) Phase 3 Overall Survival Data in The Lancet Oncology
Posted on Thursday September 13, 2018
- BRAFTOVI + MEKTOVI demonstrated a median overall survival of 33.6 months in patients with advanced BRAF-mutant melanoma in Phase 3 COLUMBUS trial - BOULDER, Colo. , Sept. 13, 2018 /PRNewswire/ -- Array ...
How Analysts View Amicus Therapeutics in September
Posted on Wednesday September 12, 2018
On September 10, Amicus Therapeutics (FOLD) announced the regulatory and clinical progress of its AT-GAA development program for Pompe disease. The company has met with the FDA to discuss the regulatory trajectory for AT-GAA, and the FDA has provided final written minutes of the meeting. Amicus Therapeutics has implemented the suggestions of the FDA and the European Medicines Agency for the study.